Pterostilbene Attenuates Fructose-Induced Myocardial Fibrosis by Inhibiting ROS-Driven Pitx2c/miR-15b Pathway

Lin-Lin Kang, Dongmei Zhang, Rui‐Qing Jiao, Shu‐Man Pan, Xiaojuan Zhao, Yan-Jing Zheng, Tianyu Chen, Ling‐Dong KongOxidative 2019 · DOI

TL;DR

This study reveals a novel molecular pathway linking excessive fructose intake to myocardial fibrosis, driven by oxidative stress, Pitx2c, and miR-15b. The antioxidant pterostilbene effectively mitigates this fibrosis by disrupting this pathway, offering a potential therapeutic strategy.

What Problem Does This Paper Address?

The paper addresses the growing problem of myocardial fibrosis, a condition that impairs heart function and can lead to heart failure. While excessive fructose consumption is known to contribute to this fibrosis through oxidative stress, the precise molecular mechanisms remain unclear. Specifically, the authors investigate how fructose-induced oxidative stress triggers fibrotic responses in heart cells and explore how an antioxidant compound, pterostilbene, might counteract these effects. Understanding these mechanisms is crucial for developing targeted therapies for fructose-induced heart damage.

Methods

The researchers employed a multi-faceted approach using both in vivo (rat models) and in vitro (H9c2 cardiac cell line) experimental systems. Key techniques included:

  • Biochemical Assays: Measuring cardiac injury biomarkers (CK-MB, cTn-T, CK, MB), hydroxyproline, hyaluronic acid, and oxidative stress markers (ROS, NADPH oxidase activity, MDA).
  • Histology and Immunohistochemistry: Examining heart tissue morphology and protein expression of fibrotic markers (ANP, α-SMA, FSP-1, TGF-β1, CTGF).
  • Molecular Biology Techniques:
    • qRT-PCR and Western Blot: Quantifying mRNA and protein levels of key players like Pitx2c, miR-15b, p53, TGF-β1, and Smad proteins.
  • miRNA Microarray: Profiling miRNA expression to identify dysregulated miRNAs in fructose-fed rats.
  • In Situ Hybridization (FISH): Localizing miR-15b expression within heart tissues.
  • Chromatin Immunoprecipitation (ChIP) Assay: Investigating the direct binding of Pitx2c to the miR-15b genetic locus.
  • siRNA and Mimic/Inhibitor Transfection: Manipulating the expression of specific genes (p53, miR-15b, CTGF, TGF-β1, Pitx2c) to elucidate their roles in the pathway.
  • ROS Scavenging: Using N-acetylcysteine (NAC) to block oxidative stress.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Fructose-ROS-Pitx2c-miR-15b Axis: The study uncovers a critical signaling cascade where fructose-induced oxidative stress leads to increased Pitx2c expression, which in turn suppresses miR-15b. This dysregulation is a central driver of myocardial fibrosis.
  • miR-15b as a Protective Factor: Low miR-15b expression appears to be a key event that allows for the activation of pro-fibrotic pathways, suggesting that restoring miR-15b levels could be protective.
  • Pitx2c's Novel Role in Fibrosis: While Pitx2c is known for its role in heart development and repair, this study highlights its detrimental role in mediating fructose-induced fibrosis by negatively regulating miR-15b.
  • Pterostilbene's Multi-Target Action: The antioxidant pterostilbene doesn't just scavenge ROS; it also directly intervenes in the Pitx2c/miR-15b axis and subsequently dampens the p-p53-dependent TGF-β1/Smads signaling pathway, demonstrating a comprehensive protective effect.
  • Therapeutic Potential: The findings strongly suggest that targeting the Pitx2c/miR-15b pathway could be a promising therapeutic strategy for managing fructose-induced myocardial fibrosis.

Key Results

  • Fructose Induces Fibrosis: Fructose feeding in rats and H9c2 cells led to increased myocardial hypertrophy and fibrosis, evidenced by elevated cardiac injury biomarkers, collagen deposition, and expression of fibrotic markers (ANP, α-SMA, FSP-1, TGF-β1, CTGF).
  • ROS and Pitx2c Upregulation: Fructose exposure significantly increased reactive oxygen species (ROS) and the expression of Pitx2c.
  • miR-15b Downregulation: Concurrently, miR-15b expression was significantly decreased in fructose-treated hearts and cells.
  • Pitx2c Negatively Regulates miR-15b: Experiments confirmed that Pitx2c directly binds to the miR-15b genetic locus and negatively regulates its expression.
  • miR-15b Deficiency Activates Pro-Fibrotic Signaling: Lowering miR-15b levels (using inhibitors or Pitx2c overexpression) led to increased p-p53, which in turn activated the TGF-β1/Smads signaling pathway and increased CTGF expression.
  • Pterostilbene's Efficacy: Pterostilbene treatment significantly ameliorated fructose-induced myocardial hypertrophy and fibrosis in both rats and H9c2 cells. It achieved this by reducing ROS, downregulating Pitx2c, upregulating miR-15b, suppressing p-p53, and inhibiting TGF-β1/Smads signaling and CTGF induction.
  • Allopurinol's Similar Effects: The positive control, allopurinol, demonstrated similar protective effects, reinforcing the role of antioxidant mechanisms.

Limitations and Future Work

  • In Vitro vs. In Vivo Relevance: While H9c2 cells are a useful model, further validation in more complex in vivo models or human studies would strengthen the findings.
  • Long-Term Effects: The study primarily focuses on the acute and sub-chronic effects of fructose. Long-term consequences and the reversibility of fibrosis with pterostilbene warrant further investigation.
  • Broader Clinical Application: While pterostilbene shows promise, its optimal dosage and long-term safety profile in human populations for cardiovascular health need more extensive research.
  • Therapeutic Target Validation: The authors suggest Pitx2c/miR-15b as a therapeutic target. Future work could focus on developing specific inhibitors or activators for this pathway and testing their efficacy in preclinical models.
  • Dietary Context: The study uses concentrated fructose. Investigating the impact of different dietary patterns and the role of other components in fructose-rich foods would provide a more comprehensive understanding.

Summary updated

Abstract

Excessive fructose consumption induces oxidative stress and myocardial fibrosis. Antioxidant compound pterostilbene has cardioprotective effect in experimental animals. This study is aimed at investigating how fructose drove fibrotic responses via oxidative stress in cardiomyocytes and explored the attenuation mechanisms of pterostilbene. We observed fructose-induced myocardial hypertrophy and fibrosis with ROS overproduction in rats. Paired-like homeodomain 2 (Pitx2c) increase, microRNA-15b (miR-15b) low expression, and p53 phosphorylation (p-p53) upregulation, as well as activation of transforming growth factor-<i>β</i>1 (TGF-<i>β</i>1)/drosophila mothers against DPP homolog (Smads) signaling and connective tissue growth factor (CTGF) induction, were also detected in fructose-fed rat hearts and fructose-exposed rat myocardial cell line H9c2 cells. The results from <i>p53</i> siRNA or <i>TGF-β1</i> siRNA transfection showed that TGF-<i>β</i>1-induced upregulation of CTGF expression and p-p53 activated TGF-<i>β</i>1/Smads signaling in fructose-exposed H9c2 cells. Of note, Pitx2c negatively modulated miR-15b expression <i>via</i> binding to the upstream of the miR-15b genetic loci by chromatin immunoprecipitation and transfection analysis with pEX1-Pitx2c plasmid and <i>Pitx2c</i> siRNA, respectively. In H9c2 cells pretreated with ROS scavenger N-acetylcysteine, or transfected with miR-15b mimic and inhibitor, fructose-induced cardiac ROS overload could drive Pitx2c-mediated miR-15b low expression, then cause p-p53-activated TGF-<i>β</i>1/Smads signaling and CTGF induction in myocardial fibrosis. We also found that pterostilbene significantly improved myocardial hypertrophy and fibrosis in fructose-fed rats and fructose-exposed H9c2 cells. Pterostilbene reduced cardiac ROS to block Pitx2c-mediated miR-15b low expression and p-p53-dependent TGF-<i>β</i>1/Smads signaling activation and CTGF induction in high fructose-induced myocardial fibrosis. These results firstly demonstrated that the ROS-driven Pitx2c/miR-15b pathway was required for p-p53-dependent TGF-<i>β</i>1/Smads signaling activation in fructose-induced myocardial fibrosis. Pterostilbene protected against high fructose-induced myocardial fibrosis through the inhibition of Pitx2c/miR-15b pathway to suppress p-p53-activated TGF-<i>β</i>1/Smads signaling, warranting the consideration of Pitx2c/miR-15b pathway as a therapeutic target in myocardial fibrosis.
BibTeX
@inproceedings{kang2019pterostilbene,
  author = {Lin-Lin Kang and Dongmei Zhang and Rui‐Qing Jiao and Shu‐Man Pan and Xiaojuan Zhao and Yan-Jing Zheng and Tianyu Chen and Ling‐Dong Kong},
  title = {{Pterostilbene Attenuates Fructose-Induced Myocardial Fibrosis by Inhibiting ROS-Driven Pitx2c/miR-15b Pathway}},
  booktitle = {Oxidative},
  year = {2019},
  doi = {10.1155/2019/1243215},
}
Figure